Literature DB >> 11512521

Does resistance to apoptosis affect clinical response to antitumor drugs?

P Borst1, J Borst, L A Smets.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11512521     DOI： 10.1054/drup.2001.0187

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN： 1368-7646            Impact factor:   18.500


× No keyword cloud information.
  6 in total

Review 1.  New clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA.

Authors:  Jan Reedijk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

2.  Therapeutic effects of survivin dominant negative mutant in a mouse model of prostate cancer.

Authors:  Li Pan; Xing-Chen Peng; Fei Leng; Qing-Zhong Yuan; Yan Shan; Dan-Dan Yu; Zhi-Yong Li; Xiang Chen; Wen-Jing Xiao; Yuan Wen; Tian-Tai Ma; Li Yang; Yong-Qiu Mao; Han-Shuo Yang; Yu-Quan Wei; Chun-Ting Wang
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-09       Impact factor: 4.553

3.  Combined treatment with lexatumumab and irradiation leads to strongly increased long term tumour control under normoxic and hypoxic conditions.

Authors:  Patrizia Marini; Dorothea Junginger; Stefan Stickl; Wilfried Budach; Maximilian Niyazi; Claus Belka
Journal:  Radiat Oncol       Date:  2009-10-27       Impact factor: 3.481

4.  Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer.

Authors:  Sven Rottenberg; Anders O H Nygren; Marina Pajic; Fijs W B van Leeuwen; Ingrid van der Heijden; Koen van de Wetering; Xiaoling Liu; Karin E de Visser; Kenneth G Gilhuijs; Olaf van Tellingen; Jan P Schouten; Jos Jonkers; Piet Borst
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-11       Impact factor: 11.205

Review 5.  Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?

Authors:  Piet Borst
Journal:  Open Biol       Date:  2012-05       Impact factor: 6.411

6.  Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs.

Authors:  Rosa Planells-Cases; Darius Lutter; Charlotte Guyader; Nora M Gerhards; Florian Ullrich; Deborah A Elger; Asli Kucukosmanoglu; Guotai Xu; Felizia K Voss; S Momsen Reincke; Tobias Stauber; Vincent A Blomen; Daniel J Vis; Lodewyk F Wessels; Thijn R Brummelkamp; Piet Borst; Sven Rottenberg; Thomas J Jentsch
Journal:  EMBO J       Date:  2015-11-03       Impact factor: 11.598
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.